JP2025516599A5 - - Google Patents

Info

Publication number
JP2025516599A5
JP2025516599A5 JP2024566373A JP2024566373A JP2025516599A5 JP 2025516599 A5 JP2025516599 A5 JP 2025516599A5 JP 2024566373 A JP2024566373 A JP 2024566373A JP 2024566373 A JP2024566373 A JP 2024566373A JP 2025516599 A5 JP2025516599 A5 JP 2025516599A5
Authority
JP
Japan
Prior art keywords
aav
expression construct
intron
coding region
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024566373A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516599A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/064152 external-priority patent/WO2023220502A1/en
Publication of JP2025516599A publication Critical patent/JP2025516599A/ja
Publication of JP2025516599A5 publication Critical patent/JP2025516599A5/ja
Pending legal-status Critical Current

Links

JP2024566373A 2022-05-12 2023-03-10 組換えパルボウイルス生成のための組成物及び方法 Pending JP2025516599A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263341201P 2022-05-12 2022-05-12
US63/341,201 2022-05-12
PCT/US2023/064152 WO2023220502A1 (en) 2022-05-12 2023-03-10 Compositions and methods for recombinant parvovirus production

Publications (2)

Publication Number Publication Date
JP2025516599A JP2025516599A (ja) 2025-05-30
JP2025516599A5 true JP2025516599A5 (cg-RX-API-DMAC7.html) 2026-02-03

Family

ID=85781807

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024566373A Pending JP2025516599A (ja) 2022-05-12 2023-03-10 組換えパルボウイルス生成のための組成物及び方法

Country Status (7)

Country Link
US (1) US20230365991A1 (cg-RX-API-DMAC7.html)
EP (1) EP4522729A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025516599A (cg-RX-API-DMAC7.html)
KR (1) KR20250009975A (cg-RX-API-DMAC7.html)
CN (1) CN119487183A (cg-RX-API-DMAC7.html)
AU (1) AU2023269763A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023220502A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026513932A (ja) * 2023-04-07 2026-05-01 リジェネクスバイオ インコーポレイテッド 組換えaav生成のための組成物及び方法
WO2025090962A1 (en) * 2023-10-25 2025-05-01 Regenxbio Inc. Compositions and methods for recombinant aav production
TW202548023A (zh) * 2024-03-14 2025-12-16 美商雅菲納治療公司 用於生產重組腺相關病毒的質體系統

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5945335A (en) * 1995-11-09 1999-08-31 Avigen, Inc. Adenovirus helper-free system for producing recombinant AAV virions lacking oncogenic sequences
US6114148C1 (en) 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
TW200403338A (en) 2002-07-16 2004-03-01 Advisys Inc Codon optimized synthetic plasmids
WO2013012771A2 (en) * 2011-07-19 2013-01-24 Wenlin Huang Clinical applications of a recombinant human endostatin adenovirus (e10a) injection
EP3870148A4 (en) * 2018-10-25 2022-11-09 Takeda Pharmaceutical Company Limited AAV TRIPLE PLASMID SYSTEM
PL3722434T3 (pl) * 2019-04-12 2022-12-12 Freeline Therapeutics Limited Układ plazmidowy
CN116096904A (zh) * 2019-12-31 2023-05-09 天鹅生物疗法有限公司 改进的aav-abcd1构建体和用于治疗或预防肾上腺脑白质营养不良(ald)和/或肾上腺脊髓神经病(amn)的用途

Similar Documents

Publication Publication Date Title
JP2022530192A5 (cg-RX-API-DMAC7.html)
JP2024009857A5 (cg-RX-API-DMAC7.html)
JP2022529631A5 (cg-RX-API-DMAC7.html)
JP2022507534A5 (cg-RX-API-DMAC7.html)
US20230323387A1 (en) Plasmid system
JP2022511348A5 (cg-RX-API-DMAC7.html)
JP2022549380A5 (cg-RX-API-DMAC7.html)
JP2020114235A5 (cg-RX-API-DMAC7.html)
JP2022530656A5 (cg-RX-API-DMAC7.html)
JP2022530544A5 (cg-RX-API-DMAC7.html)
JP2014239686A5 (cg-RX-API-DMAC7.html)
GB2592751A (en) Process for making adenoassociated viral vectors
WO2004075861A2 (en) Recombinant adeno-associated virus production
JP2020519284A5 (cg-RX-API-DMAC7.html)
WO2004020600A2 (en) Modified aav
JP2024517104A5 (cg-RX-API-DMAC7.html)
JP2023509443A5 (cg-RX-API-DMAC7.html)
KR20250135175A (ko) 아데노바이러스 헬퍼 플라스미드
JP2024542950A5 (cg-RX-API-DMAC7.html)
KR20250009975A (ko) 재조합 파르보바이러스 생산을 위한 조성물 및 방법
JP2021531044A5 (cg-RX-API-DMAC7.html)
JP2024537896A5 (cg-RX-API-DMAC7.html)
JPWO2023214579A5 (cg-RX-API-DMAC7.html)
JP2024537133A5 (cg-RX-API-DMAC7.html)
JP2023546116A5 (cg-RX-API-DMAC7.html)